To examine if the change in FCGR2B expression may simply reflect a change in the abundance of immune cells, we measured CD19, CD20 and CD11C expression, and found no significant difference in expression between controls, AA+ and T1D patients (Figure 5). Here, ITGAX is linked to type 1 diabetes mellitus.